New Perspectives of Central Nervous System Injury and Neuroprotection

New Perspectives of Central Nervous System Injury and Neuroprotection

by Elsevier Science

Hardcover

$210.00
View All Available Formats & Editions
Choose Expedited Shipping at checkout for guaranteed delivery by Wednesday, September 25

Overview

Central nervous system (CNS) diseases such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis affect a large number of populations worldwide for which no suitable cure is currently available. In addition, stroke, nanoparticle intoxication, diabetes, hypertension, and psychostimulant abuse either alone or in combination are capable of inducing potential brain damage. Thus, there is an urgent need to expand our knowledge to find suitable therapeutic strategies to enhance neurorepair processes in such diseases.

This volume presents neuroprotection and novel therapeutic strategies developed in the last 5 years by 12 world leaders in the field. The term neuroprotection means rescuing neuronal and non-neuronal cells together. The cerebral endothelium that constitutes the anatomical and physiological site of the blood-brain barrier (BBB) is one of the most important non-neural cells in the CNS. Any distortion of the BBB leads to brain diseases and restoration of the barrier results in neuroprotection. Thus, the BBB appears to be the "gateway" for neurological diseases and neurorepair. However, to treat brain tumors or infarcts, new therapeutic strategies are needed to enhance brain drug delivery using nanotechnology. In addition, apart from conventional drugs, restoration of BBB function could also be achieved by means of antibodies directed against specific proteins, neurotransmitters or exogenous supplement of neurotrophic factors. Since co-morbidity factors e.g., hypertension, diabetes, and exposure of nanoparticles could complicate the pathogenesis of neurological disorders either an enhanced dose of the drug or nanodelivery of a combination of several drugs is needed to achieve neuroprotection.

This volume of International Review of Neurobiology is the first to discuss novel therapeutic strategies in situations of neurological disorders in combination with different co-morbidity factors.




  • Reviews written by experts in such a way thatprovides basic knowledge for beginners and advanced information for researchers and experts
  • New aspects of Neurodegenerative diseasessuch as;Alzheimer’s Disease, Parkinson’s Disease, Amyotrophic Lateral Sclerosis are presented with thelatest therapeutic measures
  • Exacerbation of brain pathology in hypertension or diabetes is discussed for the first time

Product Details

ISBN-13: 9780123869869
Publisher: Elsevier Science
Publication date: 07/24/2012
Series: International Review of Neurobiology Series , #102
Pages: 424
Product dimensions: 6.20(w) x 9.10(h) x 1.10(d)

About the Author

Dr. Hari Shanker Sharma, Professor of Neurobiology (MRC), Docent in Neuroanatomy (UU) is currently working in Uppsala University Hospital, Department of Surgical Sciences, Division of Anesthesiology & Intensive Care Medicine, Uppsala University, Sweden. Dr Sharma obtained his Masters Degree from Bihar University with special expertise in Cell Biology in 1976 and was awarded the Gold Medal of Bihar University for securing 1st position in the 1st Class. Dr Sharma joined the group of Professor Prasanta Kumar Dey, a neurophysiologist, by training in the Department of Physiology, Institute of Medical; Sciences, Banaras Hindu University, Varanasi in 1977 to obtain his Doctor of Philosophy Degree (D.Phil.) in Neurosciences and was awarded his Ph.D. in 1982 on “Blood-Brain Barrier in Stress.” After carrying out a series of Government of India funded Research Projects on the BBB and brain dysfunction (1982–1987), Dr Sharma joined the lab of Neuropathology at Uppsala University with Professor Yngve Olsson in 1988 to investigate passage of tracer transport across the BBB caused by stress or traumatic insults to the Brain and Spinal cord at light and electron microscopy. Dr Sharma was awarded the prestigious Alexander von Humboldt Foundation Fellowship of German Government (1989–1991) to work on hyperthermia induced BBB dysfunction at the ultrastructural level in the laboratory of Professor Jorge Cervós-Navarro (a living “Legend in Neuropathology in Europe”). Dr Sharma again joined Uppsala University and established a network of collaboration on “Experimental CNS Injury Research Group” as a lead investigator with eminent collaborators in various parts of Europe, USA, and Australia (1991–). On his work on hyperthermia Dr Sharma received the prestigious Neuroanatomy award “Rönnows Research prize” of Uppsala University for “best neuroanatomical research of the year 1996” followed by the Award of the Degree of Doctor of Medical Sciences of Uppsala University in Neuroanatomy in 1999 and selected for the Best Thesis Award of the Medical faculty, “The Hwassers Prize” of 1999. On his meticulous works on the Blood Brain barrier and Brain edema (2000–2003) Dr. Sharma earned the prestigious title of “Docent in Neuroanatomy” of Medical Faculty, Uppsala University in April 2004. Currently his main research interest is Neuroprotection and Neuroregeneration, in relation to the Blood-brain barrier in stress, trauma, and drugs of abuse in health and disease. Dr. Sharma on his research on brain pathology and neuroprotection in different models received the prestigious award from The Laerdal Foundation of Acute Medicine, Stavanger, Norway, in 2005 followed by Distinguished International Scientists Collaboration Award by National Institute on Drug Abuse (NIDA), Baltimore, MD (2006–2008). His recent work on 5-HT3 receptor mediated neuroprotection in morphine withdrawal induced neurotoxicity won the coveted prize of Best Investigator Award 2008 and Best Scientific Presentation by European Federation of the International Association for Study of Pain (ISAP), and Awarded during their VI Annual Meeting in Lisbon, September 9–12, 2008. His recent research is aimed to find out the role of nanoparticles in Neurodegeneration and Neuroprotection using various treatment strategies that is supported by European Aerospace Research and Development (EOARD), London, UK and US Air Force Research Laboratory, Wright Patterson Air Force Base, Dayton, Oh, USA. On his works on Blood–brain barrier in hypertension and diabetes together with Romanian colleagues, University of Medicine and Pharmacy “Iuliu Hatieganu,” Cluj-Napoca, Romania awarded Dr. Sharma with Honorary Doctorate of Medical Sciences in 2009. Dr Sharma’s work over 30 years on the blood-brain barrier and brain edema won him the US Neurosurgeon Dr Anthony Marmarou Award (2011) by the International Brain Edema Society at their 15th Congress in Tokyo, Japan, November 2011. His works on Nanoneuroscience and development of nanomedicine to treat the CNS injuries has won accolades at various Government and International Scotties or Organization across the World. Accordingly Dr Sharma was decorated with the most prestigious ”Hind Rattan Award 2012” on the eve of Republic Day of India in January 2012 and Mahatma Gandhi Pravasi Gold Medal in October 2012 in House of Lords, London, UK. Dr Sharma was also invited to organize and chair Nanosymposium in Society for Neuroscience meetings in Chicago (2009), San Diego (2010), Washington DC (2011) and New Orleans (2012). Dr Sharma has published over 380 research papers, 75 reviews, 12 monographs, and 70 international book chapters and edited 15 book volumes.

Table of Contents

  1. The Function and Mechanisms of Nurr1 Action in Midbrain Dopaminergic Neurons, From Development and Maintenance to Survival
  2. Yu Luo

  3. Monoclonal Antibodies as Novel Neurotherapeutic Agents in CNS Injury and Repair
  4. Aruna Sharma and Hari S Sharma

  5. The Blood-Brain Barrier in Alzheimer’s Disease. Novel Therapeutic Targets and Nanodrug delivery
  6. Hari S Sharma, Rudy J Castellani, Mark A Smith and Aruna Sharma

  7. Neurovascular Aspects of Amyotrophic Lateral Sclerosis Maria Carolina O. Rodrigues, Diana G. Hernandez-Ontiveros, Michael K. Louis, Alison E. Willing, Cesario V. Borlongan, Paul R. Sanberg, Júlio C. Voltarelli and Svitlana Garbuzova-Davis
  8. Quercetin in Hypoxia Induced Oxidative Stress: Novel Target for Neuroprotection Anand Kumar Pandey, Ranjana Patnaik, Dafin F Muresanu, Aruna Sharma and Hari S. Sharma
  9. Environmental Conditions Modulate Neurotoxic Effects of Psychomotor Stimulant Drugs of Abuse Eugene A. Kiyatkin and Hari S. Sharma
  10. Central Nervous Tissue Damage after Hypoxia and Reperfusion in Conjunction with Cardiac Arrest and Cardiopulmonary Resuscitation. Mechanisms of Action and Possibilities for Mitigation Lars Wiklund, Cecile Martijn, Adriana Miclescu, Egidijus Semenas, Sten Rubertsson and Hari S Sharma
  11. Interactions Between Opioids and Anabolic Androgenic Steroids: Implications for The Development of Addictive Behavior Fred Nyberg and Mathias Hallberg
  12. Neurotrophic Factors and Neurodegenerative Diseases: A Delivery Issue
  13. B. Ruozi, D. Belletti, L. Bondioli, A. De Vita, F. Forni, M.A. Vandelli and G. Tosi

  14. Neuroprotective effects of cerebrolysin, a mixture of various neurotrophic factors and peptide fragments on the whole body hyperthermia-induced neurotoxicity. Modulatory Roles of co-morbidity factors and nanoparticle intoxication Hari Shanker Sharma, Aruna Sharma, Herbert Mössler andDafin Fior Muresanu
  15. Alzheimer’s Disease and Amyloid: Culprit or Coincidence? Stephen D. Skaper
  16. Vascular Endothelial Growth Factor and Other Angioglioneurins: Key Molecules in Brain Development and Restoration José Vicente Lafuente, Naiara Ortuzar, Harkaitz Bengoetxea, Susana Bulnes and Enrike G. Argandoña

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews